Zishenqing ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
49全身性エリテマトーデス1

49. 全身性エリテマトーデス


臨床試験数 : 993 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04275193
(ClinicalTrials.gov)
October 22, 201912/2/2020The Safety and Efficacy of Zishenqing in Subjects With Active Systemic Lupus ErythematosusThe Safety and Efficacy of the Traditional Chinese Medicine Zishenqing in Subjects With Active Systemic Lupus ErythematosusSystemic Lupus ErythematosusDrug: Zishenqing;Drug: PlaceboShanghai University of Traditional Chinese MedicineRenJi HospitalRecruiting18 Years65 YearsAll118Phase 2/Phase 3China